Bahamas vs Pakistan: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Bahamas
0.2%
in 2024
Pakistan
0.2%
in 2024
Bahamas rank
98th
Pakistan rank
98th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Bahamas
- Pakistan
How they compare
Bahamas currently reports 0.2% against 0.2% in Pakistan, a difference of 0.0%.
Across all 10 years both countries report, Pakistan has been ahead every year.
Bahamas ranks 98th and Pakistan ranks 98th of 246 countries.
Pakistan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bahamas | Pakistan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.3% | 0.3% | 0.1% | Pakistan |
| 2020s | 0.2% | 0.2% | 0.0% | Pakistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Bahamas or Pakistan?
- Bahamas, at 0.2% against 0.2% in Pakistan as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Bahamas and Pakistan?
- 0.0%, with Bahamas ahead.
- How many years of comparable data are there for Bahamas and Pakistan?
- 10 years are reported by both, from 2015 to 2024.
- How do Bahamas and Pakistan rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Bahamas ranks 98th and Pakistan ranks 98th of 246 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.